Ironwood Pharmaceuticals Q1 2024 Adj EPS $(0.02) Misses $0.19 Estimate, Sales $74.877M Miss $105.804M Estimate
Ironwood Pharmaceuticals Q1 2024 Adj EPS $(0.02) Misses $0.19 Estimate, Sales $74.877M Miss $105.804M Estimate
Ironwood Pharmicals 2024年第一季度经调整后每股收益美元（0.02）未达到0.19美元的预期，销售额为7,4877万美元，低于1.058.04亿美元的预期
Ironwood Pharmaceuticals (NASDAQ:IRWD) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $0.19 by 110.53 percent. This is a 108 percent decrease over earnings of $0.25 per share from the same period last year. The company reported quarterly sales of $74.877 million which missed the analyst consensus estimate of $105.804 million by 29.23 percent. This is a 28.05 percent decrease over sales of $104.061 million the same period last year.
Ironwood Pharmicals（纳斯达克股票代码：IRWD）公布的季度每股亏损为0.02美元，比分析师共识预期的0.19美元低110.53％。这比去年同期每股收益0.25美元下降了108％。该公司公布的季度销售额为7487.7万美元，比分析师普遍预期的1.058.04亿美元低29.23％。这比去年同期的1.0461亿美元的销售额下降了28.05％。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。